Subscribe to Email Alerts
Menu
About Us
About INOVIQ
Market Opportunity
Board
The Team
Partners
Distributors
Compliance
Careers
Technology
Our Science
NETs Platform
SubB2M Platform
BARD1 Biomarker Technology
hTERT ICC Assay
Intellectual Property
Publications
Resources
Business Development
Products
Our Products
EXO-NET® Pan-Exosome
Product Overview
Technical Information
Data & Figures
Ordering
hTERT ICC Test
Pipeline
Development Pipeline
SubB2M CA15-3
SubB2M CA125
Exo-Ovarian Cancer Test
Exosome Therapeutics
Investors
Investor Overview
ASX Announcements
Annual & Financial Reports
Presentations
Share Price Information
AGM
INOVIQ Fact Sheet
Corporate Governance
Shareholder Services
FAQ
Analyst Reports
News & Events
INOVIQ in the News
Conferences & Events
Contact
Contact Us
Subscribe to Email Alerts
ASX Announcements
Heading &
Sub-heading can be edited through HQI
Investors
>
ASX Announcements
Investor Overview
ASX Announcements
Annual & Financial Reports
Presentations
Share Price Information
AGM
INOVIQ Fact Sheet
Corporate Governance
Shareholder Services
FAQ
Analyst Reports
ASX Announcements
Filter by Year:
2024
2023
2022
2021
2020
2019
2018
3-Aug-2020
Change in substantial holding
30-Jul-2020
Quarterly Business Update & Appendix 4C
29-Jul-2020
Appendix 2A - Issue of Scheme Shares
28-Jul-2020
BARD1 COMPLETES SIENNA ACQUISITION
28-Jul-2020
SDX: Implementation of Scheme of Arrangement
24-Jul-2020
Appointment of Chief Scientific Officer
29-Apr-2020
Quarterly Activities Report & Appendix 4C
20-Apr-2020
Receipt of R&D Tax Incentive Refund
2-Apr-2020
BARD1 Signs Contract with Griffith University
25-Feb-2020
Half Yearly Report and Accounts
Previous
1
2
3
4
5
Next